EPICS Therapeutics Competitors and Similar CompaniesClear all
EPICS Therapeutics's competitors and similar companies include IDEAYA Biosciences, Takeda, Pharmacyclics and PharmaEssentia.
 EPICS Therapeutics EPICS Therapeutics is a drug discovery company dedicated to creating medicines in oncology. |  Takeda Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products. |  Pharmacyclics Pharmacyclics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. |  PharmaEssentia PharmaEssentia (藥華醫藥股份有限公司) is a biotech company focused on the areas of hematology, oncology, dermatology, and infectious diseases. | ||
Founding Date | Founding Date 2018 | Founding Date 2015 | Founding Date 1781 | Founding Date 1991 | Founding Date 2003 |
Type | Type Private | Type Public | Type Public | Type Subsidiary | Type Public |
Tags | |||||
Locations | Locations Charleroi, BE HQ Paris, FR | Locations South San Francisco, US HQ San Diego, US | Locations Sunnyvale, US HQ | Locations Taipei, TW HQ Shinjuku City, JP Burlington, US | |
Employees | Employees 28 | Employees 56 | Employees 47,4554% decrease | Employees 6551% decrease | Employees 4897% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 2.5 b | Valuation ($) 43.7 b | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $218.7m (FY, 2025) | Revenue (est.) ¥4.6t (FY, 2025) | Revenue (est.) $729.7m (FY, 2014) | Revenue (est.) NT$15.6b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods ¥818.8b (FY, 2025) | Cost of goods $40.4m (FY, 2014) | Cost of goods NT$1.3b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit ¥3.8t (FY, 2025) | Gross profit $689.3m (FY, 2014) | Gross profit NT$14.4b (FY, 2025) |
Net income | Net income N/A | Net income ($113.7m) (FY, 2025) | Net income ¥108.1b (FY, 2025) | Net income $86.1m (FY, 2014) | Net income NT$5b (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised $ 8.4m | Total funding raised $ 140m | Total funding raised $ 57.8m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
IDEAYA Biosciences
HQ
South San Francisco, US
Employees
56
IDEAYA Biosciences (IDEAYA) is a developer of molecular therapies.
View companyTakeda
HQ
Tokyo, JP
Employees
47,455↓ 4% decrease
Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products.
View companyPharmacyclics
HQ
Sunnyvale, US
Pharmacyclics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases.
View companyPharmaEssentia
HQ
Taipei, TW
Employees
489↑ 7% increase
PharmaEssentia (藥華醫藥股份有限公司) is a biotech company focused on the areas of hematology, oncology, dermatology, and infectious diseases.
View company